Vol 4 (June 30, 2021): Precision Cancer Medicine

Editorial Commentary
Management of acquired resistance to ALK inhibitors: repeat biopsy to characterize mechanisms of resistance significantly impacts clinical outcomes
Aparna Hegde, Maya Khalil
Precision Cancer Medicine  
2021;
4:
20  
(30 June 2021) 
PDF Full Text (2498) COI Form Open Access Get Permission
Editorial Commentary
PARP inhibitors beyond BRCA-mutated cancers: precision medicine at the crossroads
Bartłomiej Tomasik, Michał Bieńkowski, Jacek Jassem
Precision Cancer Medicine  
2021;
4:
19  
(30 June 2021) 
PDF Full Text (4470) COI Form Open Access Get Permission
Editorial Commentary
Lung cancer screening: think pink!
Monica Casiraghi, Lorenzo Spaggiari
Precision Cancer Medicine  
2021;
4:
18  
(30 June 2021) 
PDF Full Text (841) COI Form Open Access Get Permission
Case Report
Effectiveness of pemetrexed-based chemotherapy and radiation therapy in RET-rearranged lung adenocarcinoma: a mono-institutional case series
Fabrizio Citarella, Marco Russano, Alessandro Galletti, Giuseppina-Rita Di Fazio, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2021;
4:
17  
(30 June 2021) 
PDF Full Text (1498) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Review Article
ROS-1 NSCLC therapy resistance mechanism
Miguel García-Pardo, Antonio Calles
Precision Cancer Medicine  
2021;
4:
16  
(30 June 2021) 
PDF Full Text (4955) COI Form Open Access Get Permission
Review Article
Monitoring therapeutic response and resistance with liquid biopsy
Virginia Calvo, Atocha Romero, Mariano Provencio
Precision Cancer Medicine  
2021;
4:
15  
(30 June 2021) 
PDF Full Text (870) COI Form Open Access Get Permission
Review Article
Non-small cell lung cancer molecular characterization of advanced disease with focus on sex differences: a narrative review
Rossella Bruno, Greta Alì, Anello Marcello Poma, Gabriella Fontanini
Precision Cancer Medicine  
2021;
4:
14  
(30 June 2021) 
PDF Full Text (2945) Reporting Checklist COI Form Open Access Get Permission
Review Article
A narrative review of chemotherapy in advanced triple negative breast cancer
Maria L. Romero Lagunes, Rossanna C. Pezo
Precision Cancer Medicine  
2021;
4:
13  
(30 June 2021) 
PDF Full Text (3709) Reporting Checklist COI Form Open Access Get Permission
Review Article
Triple negative breast cancer: emerging light on the horizon—a narrative review
Umangjot K. Bharaj, Ana E. Lohmann, Phillip S. Blanchette
Precision Cancer Medicine  
2021;
4:
12  
(30 June 2021) 
PDF Full Text (1601) Reporting Checklist COI Form Open Access Get Permission
Original Article
The use of stereotactic body radiotherapy in pulmonary carcinoid tumors: a case series
Katharine Thomas, Chris Smith, Andrew Marsala, John Philip Boudreaux, Ramcharan Thiagarajan, Robert A. Ramirez
Precision Cancer Medicine  
2021;
4:
11  
(30 June 2021) 
PDF Full Text (1735) Reporting Checklist Data Sharing Statement COI Form Open Access Get Permission